Suresh Pallikkuth Selected Research

Suresh Pallikkuth Research Topics

Disease

27	HIV Infections (HIV Infection) 10/2021 - 12/2009
13	Inflammation (Inflammations) 01/2022 - 01/2013
9	Infections 06/2022 - 01/2013
9	Human Influenza (Influenza) 10/2021 - 08/2012
3	Virus Diseases (Viral Diseases) 11/2019 - 08/2012
3	Substance-Related Disorders (Drug Abuse) 01/2019 - 01/2018
2	Reinfection 06/2022 - 01/2022
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
2	COVID-19 01/2021 - 11/2020
2	Malaria 01/2021 - 01/2020
1	Hypoxia (Hypoxemia) 06/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Obesity 01/2022
1	Parasitemia 01/2021
1	Latent Infection 01/2020
1	Neoplasms (Cancer) 11/2019
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017
1	Persistent Infection 01/2013

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 10/2021 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
8	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2021 - 08/2012
8	interleukin-21 (interleukin 21)IBA 10/2021 - 11/2011
8	AntigensIBA 10/2021 - 01/2017
5	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2020 - 01/2018
3	CytokinesIBA 01/2022 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
3	Lipopolysaccharide ReceptorsIBA 12/2019 - 01/2013
2	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 10/2017
2	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2018
2	AIDS VaccinesIBA 01/2020 - 11/2011
2	LipopolysaccharidesIBA 12/2019 - 01/2018
2	Biological ProductsIBA 10/2017 - 01/2017
1	Messenger RNA (mRNA)IBA 06/2022
1	Peptides (Polypeptides)IBA 06/2022
1	Immunoglobulin G (IgG)IBA 06/2022
1	COVID-19 VaccinesIBA 01/2022
1	CholesterolIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	baricitinibIBA 01/2021
1	SolutionsIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	ruxolitinibIBA 01/2021
1	NeopterinIBA 01/2021
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2021
1	diformyl dapsone (DFD)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Malaria VaccinesIBA 01/2020
1	ImmunosorbentsIBA 12/2019
1	C-Reactive ProteinIBA 12/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2019
1	EnzymesIBA 12/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2019
1	IntegrinsIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Fatty Acid-Binding ProteinsIBA 01/2018
1	Vaccine AdjuvantsIBA 12/2013
1	Raltegravir Potassium FDA Link 11/2013
1	Viral Envelope ProteinsIBA 05/2013
1	Integrase InhibitorsIBA 05/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Interleukin-21 ReceptorsIBA 01/2012
1	Glutathione (Reduced Glutathione)IBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 12/2009

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2009
5	Art Therapy 10/2021 - 01/2019
3	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 11/2013
1	Transplantation 06/2022
1	Immunotherapy 01/2018